Walmart Settles DOJ Opioid Suit for $50M, Calls Payout 'Immaterial'
WMT is trading near its 52-week low of $95.7 (7.7% above the low).
Summary
Walmart agreed to pay $50 million to settle a DOJ lawsuit alleging its pharmacies unlawfully filled opioid prescriptions. The company admitted no wrongdoing and called the payout immaterial in a regulatory filing. The settlement is a fraction of the billions in civil penalties initially sought when the suit was filed in December 2020. This follows Walmart's Q2 FY27 10-Q filed yesterday, which disclosed settlements of two opioid-related lawsuits. The $50 million is negligible against Walmart's $11.79 billion net income for the six months ended July 31, so the financial impact is minimal, but it removes a long-standing legal overhang.
At the time of this announcement, WMT was trading at $103.08 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $820.4B. The 52-week trading range was $95.70 to $135.16. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Benzinga.